Prognica Labs
Prognica Labs has developed a cancer diagnostics and treatment platform that leverages the power of artificial intelligence and machine learning to improve clinical outcomes as well as to reduce costs.
Prognica Labs is a healthtech company that aims to streamline clinical encounters and optimize outcomes through predictive analytics to improve clinical outcomes, and thereby accelerate the discovery of breakthrough advancements in the fight against cancer. Prognica utilizes evidence-based algorithms, machine learning, and computer vision to generate real-time clinical insights at all points of care through early detection and intervention. The enterprise is also constantly working towards bringing top global talent to UAE from renowned educational institutions such as Harvard, Yale, Massachusetts Institute of Technology, Brown University, and others, to participate as its advisors in life sciences and public health.
- FOUNDED IN: 2019
- SECTOR: HEALTHTECH
“We have a strong mission at Prognica Labs: to democratize the early detection and diagnosis of breast cancer by making the entire process more accurate, accessible and affordable.”
Click here to see the full Future 100 list.
Prognica Labs is a healthtech company that aims to streamline clinical encounters and optimize outcomes through predictive analytics to improve clinical outcomes, and thereby accelerate the discovery of breakthrough advancements in the fight against cancer. Prognica utilizes evidence-based algorithms, machine learning, and computer vision to generate real-time clinical insights at all points of care through early detection and intervention. The enterprise is also constantly working towards bringing top global talent to UAE from renowned educational institutions such as Harvard, Yale, Massachusetts Institute of Technology, Brown University, and others, to participate as its advisors in life sciences and public health.
- FOUNDED IN: 2019
- SECTOR: HEALTHTECH
“We have a strong mission at Prognica Labs: to democratize the early detection and diagnosis of breast cancer by making the entire process more accurate, accessible and affordable.”
Click here to see the full Future 100 list.
